Predictive value of neoadjuvant chemotherapy for the clinical utility of subsequently performed major cancer surgery Maurie Markman Editor’s Commentary 23 November 2008 Pages: 447 - 448
Relapsed acute lymphocytic leukemia Robert J. Wells Clinical Trials Report 23 November 2008 Pages: 451 - 452
Relapsed acute lymphoblastic leukemia: Current status and future opportunities Theresa M. HarnedPaul S. Gaynon OriginalPaper 23 November 2008 Pages: 453 - 458
Notch signaling in pediatric malignancies Patrick A. Zweidler-McKay OriginalPaper 23 November 2008 Pages: 459 - 468
Psychosocial support of the pediatric cancer patient: Lessons learned over the past 50 years Martha A. AskinsBartlett D. Moore OriginalPaper 23 November 2008 Pages: 469 - 476
Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials Margaret E. MacyKelly K. SawczynLia Gore OriginalPaper 23 November 2008 Pages: 477 - 490
Lymphatic mapping for vulvar cancer: Ready for “Prime-Time?” Robert L. Coleman Clinical Trials Report 23 November 2008 Pages: 493 - 496
Gestational trophoblastic neoplasia: an update Jacqueline M. MorganJohn R. Lurain OriginalPaper 23 November 2008 Pages: 497 - 504
Uterine papillary serous carcinoma: State of the state R. Wendel Naumann OriginalPaper 23 November 2008 Pages: 505 - 511
Low-grade serous ovarian cancer: a unique disease Kathleen M. SchmelerDavid M. Gershenson OriginalPaper 23 November 2008 Pages: 519 - 523
Ultrasound for the screening of breast cancer Therese B. Bevers Clinical Trials Report 23 November 2008 Pages: 527 - 528
Prostate cancer chemoprevention: Update of the prostate cancer prevention trial findings and implications for clinical practice Jamey A. SarvisIan M. Thompson OriginalPaper 23 November 2008 Pages: 529 - 532
Human papillomavirus testing for primary cervical cancer screening Carolyn D. RunowiczStephanie Garozzo OriginalPaper 23 November 2008 Pages: 533 - 537
